StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Laboratory Corporation of America (LH) PT Raised to $260 at BofA Securities
August 5, 2024 5:41 AM
BofA Securities analyst Derik de Bruin raised the price target on Laboratory Corporation of America (NYSE: LH) to $260.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Form 10-Q LABCORP HOLDINGS INC. For: Jun 30
August 2, 2024 2:38 PM
Laboratory Corporation of America (LH) PT Raised to $277 at Baird
August 2, 2024 9:02 AM
Laboratory Corporation of America (LH) PT Raised to $270 at UBS
August 2, 2024 8:44 AM
Labcorp (LH) Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx
August 2, 2024 8:33 AM
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx
August 2, 2024 8:30 AM
Laboratory Corporation of America (LH) PT Raised to $275 at Truist Securities
August 2, 2024 7:55 AM
Laboratory Corporation of America (LH) PT Raised to $256 at Mizuho
August 2, 2024 7:00 AM
Laboratory Corporation of America (LH) PT Raised to $249 at Barclays
August 2, 2024 6:02 AM
Midday movers: Meta Platforms, Lilly rise; Arm, Moderna fall
August 1, 2024 8:07 AM
Labcorp beats Q2 profit and revenue estimates on demand for health tests
August 1, 2024 7:28 AM
Form 8-K LABCORP HOLDINGS INC. For: Aug 01
August 1, 2024 7:05 AM
Labcorp Announces 2024 Second Quarter Results
August 1, 2024 6:58 AM
